Category: Guillain-Barré syndrome

Rare Disease Erupts in Peru; WHO to Authenticate Health Records; Surprising Habits That Damage Liver

The Peruvian government declares a national health emergency due to a rise of a rare autoimmune disease. The Guillain-Barré syndrome (GBS) is a known side effect of some vaccines, including the COVID-19 shots. Peru is one of the highest vaccinated countries in the world against COVID. So what are they doing about GBS? And what…


Guillain-Barré Syndrome Linked to COVID-19 Vaccine: CDC Study

A disruptive syndrome may be caused by one of the COVID-19 vaccines available in the United States, U.S. officials said in a new study. Seventy-three cases of Guillain-Barré Syndrome, which causes the immune system to attack parts of the nervous system, were confirmed in adults within 42 days of vaccination with Johnson & Johnson’s shot, the U.S. Centers…


COVID Vax Compensation Recipient ‘Disheartened’ Over Lack of Recognition of the Vaccine Injured

Ross Wightman, who was diagnosed with Guillain-Barré syndrome shortly after receiving a dose of the AstraZeneca COVID-19 vaccine, has become one of the first recipients of funds under Canada’s Vaccine Injury Support Program. But the plight of others who have suffered vaccine injuries weighs heavily on the realtor and former pilot from B.C.’s Okanagan Valley….


‘Significant’ Cases of Neurological Disorder Associated with the AstraZeneca Vaccine

A UK study by University College London has confirmed “small but significant” cases of the serious Guillain-Barre syndrome (GBS), a rare neurological disorder associated with the AstraZeneca vaccine for COVID-19. The researchers speculate that the “the majority or all” of the 121 UK cases of GBS (pdf) in March to April 2021 were associated with first…


Rare Nerve Disorder Listed as COVID-19 Vaccine Side Effect by EU

The European Union’s drug regulator listed a rare nerve disorder known as Guillain-Barré syndrome (GBS) as a possible AstraZeneca COVID-19 vaccine side effect, according to the watchdog in a Wednesday update. The European Medicines Agency (EMA) said the AstraZeneca shot, known as Vaxzevria, was associated with 833 GBS cases as of July 31. That’s out of 592 million…


Benefits of Johnson & Johnson COVID-19 Vaccine ‘Continue to Outweigh’ the Risk of Neurological Disorder: CDC Advisory Panel

The vaccine advisory panel to the Centers for Disease Control and Prevention (CDC) said on Thursday that the benefits of Johnson & Johnson’s COVID-19 vaccine still outweigh the risk of a serious, but rare, neurological disorder following vaccination. The Advisory Committee on Immunization Practices met to discuss the incidence of Guillain-Barré syndrome (GBS) following a…